DASSAULT AVIATION

French corporation (société anonyme) with a share capital of 66,789,624 euros
Headquarters: 9, Rond-Point des Champs-Elysées Marcel Dassault – 75008 PARIS
RCS PARIS 712 042 456

Information concerning the total number of voting rights and shares as per article L. 233-8 II of the French Commercial Code (Code de commerce) and article 223-16 of the General Regulations (Règlement Général) of the French Market Authority (Autorité des Marchés Financiers)

Attachment

• Total number of shares and voting rights – 31 03 21

Coinsmart. Beste Bitcoin-Börse in Europa
Source: http://www.globenewswire.com/news-release/2021/04/01/2203555/0/en/Dassault-Aviation-Total-number-of-shares-and-voting-rights-31-03-21.html

DASSAULT AVIATION

Société anonyme au capital de 66 789 624 euros
Siège social : 9, Rond-Point des Champs-Elysées Marcel Dassault
75008 PARIS
RCS PARIS 712 042 456

Informations relatives au nombre total de droits de vote et d’actions prévues par les articles L. 233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers

Pièce jointe

• Nombre total actions et droits de vote au 31 03 21

Coinsmart. Beste Bitcoin-Börse in Europa
Source: http://www.globenewswire.com/news-release/2021/04/01/2203555/0/fr/Dassault-Aviation-Nombre-total-actions-et-droits-de-vote-au-31-03-21.html

BOCA RATON, Fla., April 01, 2021 (GLOBE NEWSWIRE) — Xeriant, Inc. (OTC PINK: XERI), a new aerospace technology holding company, announced today that its Czech Republic affiliate, Xeriant Europe s.r.o., has entered into a joint venture with Movychem s.r.o. (“Movychem”), a 27-year-old chemical company based in Slovakia, primarily to further develop applications and new markets for its breakthrough “green” fire retardant and fire resistant products under the brand name Retacell. Under the agreement, Xeriant Europe has a 50 percent stake in Movychem Holdings s.r.o., which will hold all intellectual property rights and patents, as well as exclusivity for distribution of Movychem products in the U.S. market.

“The Movychem JV is consistent with our strategy to acquire technologies that advance sustainability and safety in aerospace and can produce near-term revenue. Many of these innovations have applications in other industries. The new electric aircraft being developed will need to be optimized for aerodynamics and lightweighting, as well as safety, and Movychem’s Retacell has the potential to play a critical role in this mission,” stated Keith Duffy, CEO of Xeriant Aerospace.

Retacell is a breakthrough eco-friendly fire and thermal protection technology that is biodegradable and non-toxic, and can be infused into a variety of plastics, foams, sealants, fillers, adhesives and coatings, as well as textiles and wood-derived products. Movychem is in the process of initiating testing on Retacell treated plastics, textiles, wood-derived materials and carbon fiber. The number of potential applications is almost unlimited in the transportation and construction industries.

The breakthrough thermal and fire protection properties of Retacell could have broad implications in aerospace for the engine, wiring, structural and interior components of flight vehicles, including the insulation of batteries utilized in electric aircraft propulsion systems. Movychem initially plans to test Retacell on the thermoplastics and foams used in aircraft cabin interiors, for floors, ceilings, wall panels and seats. To achieve certification, Movychem plans to work with aircraft materials suppliers, component manufacturers and major airframe manufacturers to produce the safest and most durable materials, with the goal of exceeding all fire, smoke and toxicity requirements according to Federal Aviation Regulations.

“We invested nearly 20 years of R&D in Retacell to make this one of most important advancements in fire and heat protection. Our product is more cost-effective and safer for the environment than competing technologies, and there is greater application flexibility. Teaming up with Xeriant will best position our efforts to not only enter the U.S. market, but to compete for a piece of the global vehicle interiors markets, including aircraft and automobiles, as well as construction materials,” commented JUDr. Lubos Nemecek, Managing Member of Movychem.

About Movychem s.r.o.

Founded in 1993, Movychem s.r.o. (“Movychem”), the creator of Retacell, is a chemical manufacturing company that develops and distributes specialty materials, primarily in Central Europe. Their product line includes sealants, adhesives, fillers, additives, colorants, paints, coatings, fire retardants, and waterproofing materials for a variety of industries and applications. In 2001, Movychem began its research, development and testing of its fire and thermal protection technologies, called Retacell, which led to several global patents. Until 2019, the company was not engaged in the marketing and distribution of Retacell, because its focus was on R&D, testing and certification.

About Xeriant Europe

Xeriant Europe s.r.o., headquartered in Prague, Czech Republic, was founded with the purpose of identifying leading-edge green technologies with applications in aerospace, primarily from the Czech Republic, and promoting them on the world market, especially in the U.S. The company’s focus is on unique products that are either already being sold or are close to commercialization.

About Xeriant

Xeriant, Inc. (d.b.a. Xeriant Aerospace) is a holding and operating company focused on acquiring, developing, and commercializing revolutionary, eco-friendly technologies with applications in aerospace, including innovative aircraft concepts targeting emerging opportunities within the aviation industry. In 2019, Xeriant acquired a unique, scalable, multi-purpose VTOL aerial platform called Halo, which is protected under a broad utility patent. Xeriant is located at the Research Park at Florida Atlantic University in Boca Raton, Florida adjacent to the Boca Raton Airport. The Company is an OTC Markets public company trading under the stock symbol, XERI.

For more information, please go to www.xeriant.com

SAFE HARBOR FORWARD-LOOKING STATEMENTS

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Xeriant, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our expectations concerning our ability to attract investors.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

XERIANT, INC. CORPORATE

Investor Relations:
Matt Chipman
(818) 923-5302
IR@xeriant.com
www.xeriant.com

Coinsmart. Beste Bitcoin-Börse in Europa
Source: http://www.globenewswire.com/news-release/2021/04/01/2203274/0/en/Xeriant-Signs-Joint-Venture-with-Movychem.html

FY 2020: in accordance with the strategic plan,
EBITDA is close to break-even in the second half of the year

March 31, 2021 to 6 PM.
Key points

• Excluding non-recurring expenses, EBITDA was close to break-even in the second half of the year (negative of 0.65 million euros).
• The volume of activity for the year (revenues) was stable at almost 17 million euros, despite a turnover impacted by billing deferrals related to the health crisis and taking into account 3.8 million euros of sales sold during the year.
• The backlog (signed contracts) is close to 25 million euros.
• At the end of 2020, the group’s financial structure is solid, with 12.6 million euros of equity, net cash of 4.7 million euros and limited financial indebtedness of 1.7 million euros.

*          Non-recurring operating expenses are those identified in the year corresponding to the activities sold and discontinued, as well as the staff costs of employees who have left and not replaced.

**        DAP: Depreciation and amortization allowances and provisions

Improved operational performance:

Revenues:
The inventoried products, essentially 20 automatic ISS Spotter systems, have been marketed or are in the process of being marketed. The shipment and installation of several of these systems had to be delayed due to the health crisis.

The Countbot inventory solution represents the majority of the capitalised production and will allow the development and deployment of the solution in the context of service missions, as soon as the general context is more favourable.

Purchases of goods and raw materials consumed:
For the past two years, it was the launch of industrial production in the first pre-series of professional solutions.

Other external purchases and expenses:
The drop of 300K euros between 2019 and 2020 is a direct result of the management efforts carried out under the 2020-2021 plan.

Staff costs:
The cost reduction of 1.2 million euros also proves the efforts made to follow the plan. It resolutly contributes to the objective of achieving a fixed level of expenses in line with a profitable operation, without jeopardizing the Group’s development. Indeed, the staff out of the workforce corresponds to a rationalization of the organization more in line with the Activities of the Group.

Non-recurring expenses:
The sale and discontinuation of several activities and entities that have become non-strategic and structurally loss-making explain the importance of the level reached in 2020. The complete disappearance of these expenses as early as the 2021 financial year will contribute decisively to the objective of reaching the break-even point for the Group.

Financial result:
The financial result increased from a positive balance of 513K euros in 2019 to a deficit of 583K euros in 2020, a deterioration of 1.1 million euros. These movements and their balance are always mostly registered with no impact on cash flow and in connection with the in-depth reorganization of the Group’s organization chart.

Exceptional result:
The exceptional result was strongly negative at 2.1 million euros. In particular, it corresponds to costs related to the operations of discontinuation of activities and disposal of entities, in connection with the effects also observed in terms of the financial result.

Equity and related assets:
Thanks to the financing program set up with the investment fund Yorkville Advisors, the Group can continue to pursue its development program with serenity, while securing its financial structure. This strategic choice is reinforced over the months, as the outcome of the health crisis remains uncertain, especially in terms of its inevitable economic consequences, while limiting indebtedness to institutional financial partners whose excessive and uncontrolled recourse would necessarily lead to a dangerous development in the coming years.

Net cash:
As of March 19, 2021, net cash amounted to 3.1 million euros.

Nb. The Group’s detailed accounts are available in French and English on the Group’s website (www.deltadrone.com).

Continuation of the 2020-2021 strategic plan:

It should be recalled in the preamble that the Group’s management is part of the 2020-2021 plan, the three main areas of which are a consolidated turnover of 30 million euros, a positive operating profitability equal to 10% of turnover and 30% of the activity carried out outside France.
The implementation of this plan is based on an organisation in two areas of activity, professional solutions and associated services, on the other hand on dynamic international development, mainly in Africa and Oceania. It requires sufficient financial resources to be carried out because it requires significant investments, both in terms of research and development, and industrialization, as well as in the resources needed for commercial development.

In terms of systems designed and manufactured, it is important to be particularly vigilant at a time when a “new world order” is emerging in the sector of civilian drones for professional use, gradually excluding any components of Chinese origin. Historically, Delta Drone has always chosen proprietary designs by using “on-shelf” components from Asia in a very marginal way. On the other hand, this evolution is likely to turn the tables on many players in the sector, often simple assemblers from purchased technologies.

Finally, it should be stressed that the strategy developed by the Group also relies on taking a stake in companies in the international drone ecosystem, so as to enable Delta Drone to have privileged relationships with innovative companies whose activities are in synergy with its own technical and commercial developments.

In the final analysis, the weight of the health crisis and the related uncertainties, especially over its duration, make it very difficult to project on the future.

The three major axes described in the 2020-2021 plan remain achievable, obviously more random. In this context, the Group continues to focus on achieving a profitability situation. The figures for fiscal year 2020, and even more so in the second half of the year, are encouraging in this regard and put us on the right track.

About Delta Drone: Delta Drone Group is a recognized international player in the civil drone industry for professional use. It develops a range of professional solutions based on drone technology as well as all associated services that form a complete value chain.
Delta Drone shares are listed on the Euronext Growth Paris market – ISIN Code: FR0011522168
Also listed on Euronext Growth of BSA Y – Code ISIN: FR 0013400991

www.deltadrone.com

Investor Contacts:                                                                Press Contact:

Attachment

• 20210331_PR DELTADRONE_FY2020 VDEF

Coinsmart. Beste Bitcoin-Börse in Europa
Source: http://www.globenewswire.com/news-release/2021/03/31/2202685/0/en/DELTA-DRONE-FY-2020-in-accordance-with-the-strategic-plan-EBITDA-is-close-to-break-even-in-the-second-half-of-the-year.html